Blood Pressure Program Modestly Reduced New Dementia Cases in Rural China

CATEGORY: DISEASE PREVENTION

Can bringing blood pressure down hold dementia off? A trial across 326 villages in rural China set out to test exactly that. Dementia turned up about 15% less often over four years among adults with uncontrolled high blood pressure who got extra help lowering it, compared with adults left on usual care.¹ Which villages received which program was decided at random, so this carries more weight than the observational studies that usually take on the question.

33,995 Adults, Community Health Workers, Four Years of Tracking

The trial enrolled 33,995 adults aged 40 and older whose high blood pressure was not under control. High blood pressure is a persistent elevation in the force of blood pushing against artery walls. In half the villages, trained community health workers helped residents lower it with medication and coaching on diet, salt, weight and activity. The other half carried on with usual local care. Over four years the teams tracked new cases of dementia, a lasting loss of memory and thinking ability serious enough to disrupt daily life, using standard memory and daily-function assessments.

Systolic Pressure Fell 22 Points Further

The extra support did what it was meant to do. The intervention group’s top number, the systolic pressure, fell about 22 points more than in usual care. Dementia risk came out roughly 15% lower, a difference unlikely to be due to chance. All-cause dementia was the outcome the trial had been designed around, and the gap between groups reached statistical significance.¹ Serious health problems overall were slightly less common in the treated group too.¹ Years of high pressure quietly damage the small blood vessels feeding the brain, cutting blood flow and contributing to the tiny areas of injury seen in both vascular dementia and Alzheimer’s disease. Easing that strain is the likeliest explanation for what the trial recorded.

One Package, One Setting, Mixed Evidence Elsewhere

What was tested was a package: medication plus lifestyle coaching, delivered in one specific rural setting. It does not separate the parts, and it says nothing about any individual’s treatment. Other trial evidence runs in the same direction, with limits. A pooled analysis of five placebo-controlled trials in 28,008 adults found blood pressure-lowering drugs linked to about 13% lower odds of dementia.² SPRINT MIND, a large U.S. trial of intensive treatment, found 19% fewer cases of mild cognitive impairment, meaning early memory and thinking trouble that has not reached dementia. Its difference in dementia itself could have been chance.³

Key Takeaways

• Helping adults with uncontrolled high blood pressure bring it down went with about 15% fewer dementia cases over four years.
• Villages were allocated at random, which makes this stronger evidence than an observational study.
• The benefit arrived alongside a 22-point larger drop in systolic pressure, from a program that combined medication with lifestyle support.

References

1. He J, Zhao C, Zhong S, et al. Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trial. Nature Medicine. 2025;31(6):2054–2061. link
2. Peters R, Xu Y, Fitzgerald O, et al. Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis. European Heart Journal. 2022;43(48):4980–4990. link.
3. Williamson JD, Pajewski NM, Auchus AP, et al. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019;321(6):553–561. link.